Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RESMED INCRMD · Entity 2692 | Director | November 20, 2025 | November 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RESMED INC
Report date November 20, 2025 · Filed November 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 10,940 |
Reported balance
After 2025-11-20 transaction · row 1
1 source rowRow 1 · 2025-11-20 · Grant · Acquired 1,073 · Balance 10,940 F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2025 Filed Nov 24, 2025 16:12 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-25-000175 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,940 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. Read SEC document |
| November 11, 2025 Filed Nov 14, 2025 14:13 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 38.209 | $250.10 | $9,556.07 |
DisclosureSEC source: 0000943819-25-000119 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,867 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:20 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027900 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,905 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| November 11, 2024 Filed Nov 12, 2024 22:57 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 132.601 | $252.38 | $33,465.84 |
DisclosureSEC source: 0001127602-24-027099 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,822 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023. Read SEC document |
| November 16, 2023 Filed Nov 21, 2023 01:21 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-028086 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,955 F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:11 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 79.202 | $143.60 | $11,373.41 |
DisclosureSEC source: 0001127602-23-027452 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,187 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 22:59 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026072 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,266 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 11, 2022 Filed Nov 16, 2022 00:35 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 41 | $225.18 | $9,232.38 |
DisclosureSEC source: 0001127602-22-025667 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,144 F1 · kind: Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/18/2021. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 23:57 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 956 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-21-000035 · primary_doc.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,185 F1 · shares: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2022, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 27, 2020 Filed Dec 1, 2020 01:33 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 116 | $212.11 | $24,604.76 |
DisclosureSEC source: 0001127602-20-030148 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,229 F1 · kind: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/21/2019. Read SEC document |
| November 19, 2020 Filed Nov 21, 2020 00:12 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-029761 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2021, or the annual shareholders meeting in the year following the grant date. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:35 UTC | RESMED INC RMD · Entity 2692 | Tax withholdingResMed Common Stock | 102 | $143.88 | $14,675.76 |
DisclosureSEC source: 0001127602-19-033988 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,158 Read SEC document |
| November 21, 2019 Filed Nov 25, 2019 20:24 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-033666 · form4.xml · nonDerivative · entry 1 Gill Harjit · CIK 0001759311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2020, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.